CUNNINGHAM MARK has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and United Kingdom. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are APPLIED MOLECULAR EVOLUTION, LEDBETTER JEFFREY A and APOGENIX GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | United Kingdom | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Cunningham Mark | 9 |
#2 | San Mateo Lani | 7 |
#3 | Sweet Raymond | 7 |
#4 | Teplyakov Alexey | 7 |
#5 | Sarisky Robert | 7 |
#6 | Feng Yiqing | 7 |
#7 | Wu Sheng-Jiun | 7 |
#8 | Rauchenberger Robert | 7 |
#9 | Rutz Mark | 7 |
#10 | Teng Fang | 7 |
Publication | Filing date | Title |
---|---|---|
GB202002536D0 | Air purifier with combined led luminairies with decorative outer shades | |
GB202002433D0 | Combined air purifier and linear led luminaire (db59) | |
GB202002108D0 | 160-110 Air purifier with integrated LED Luminaire | |
US2013090457A1 | Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases | |
US2012064095A1 | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |